Abstract
Despite improved dialysis techniques, in combination with balanced infusion therapy, early regulation of the water, electrolyte and acid/base metabolism and specific antibiotic therapy, acute renal failure, (ARF) has 29–69 % mortality rates. During the last 1 1/2 years, patients in ARF received in addition to the mentioned standard therapy, Trasylol by continuous drip infusion of usually 1 million KIU in 24 hours. Trasylol inhibits besides trypsin, chymotrypsin, plasmin and the kallikreins which are responsible for the liberation of kinin, as well as leukocytic lysosomal proteinases; these enzyme systems are mainly held responsible for the tubular damage to the kidneys, and in conjunction with oxygen deficiency and other noxae such as bacterial toxins, endogenous poisons and bilirubin, they induce ARF.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dittrich, P., H.J. Gurland, M. Kessel, M.A. Massini, E. Wetzels: Haemodialysis and Peritoneal Dialysis. Pages 243, 272, and 277. Edited by E. Wetzels — Springer, Berlin-Heidelberg-New York, 1969.
Braun, I.: for Prognosis of Acute Renal Insufficiency. IN: Peter v. Dittrich and Klaus F. Kopp: Actual Problems involved with Dialysis Procedures and Renal Insufficiency. Pages 172, 174 and 177. II. Symposium Innsbruck, 1967. Priedberg, 1968.
Hoeltzenbein, J.: The Artificial Kidney. Pages 212, 213, and 214. Edited by P. Enke, Stuttgart, 1969.
Braun, L.: The Acute Kidney Failure. Pages 3, 4, 5. Edited by P. Enke, Stuttgart, 1968.
Truss, P.: Medical World, 1968, pages 1845 — 1851.
Thurau, K.: The intrarenal roll of the Renin-Angiotensin system in the regulation of the Glomerulu-min filtrate and of sodium excretion. In: Actual Problems of Nephrology. Pages 75–87. IV. Symposium Saarbruecken and Homburg/Saar, 1965. Springer, Berlin-Heidelberg-New York, 1966.
Back, N. and H. Wilkens: The Effects of Trasylol on Microcirculatory Phenomena. IN: G.L. Haberland and P. Matis: New Aspects of Trasylol Therapy, pages 61–73. Symposium Munich, 1968. Edited by Schattauer, Stuttgart-New York, 1969.
Werle, E.: To the Biochemistry of Trasylol. In: G.L. Haberland, P. Matis: New Aspects of Trasylol Therapy, pages 49-59. Symposium in Munich, 1968. Edited by Schattauer, Stuttgart-New York, 1969.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1970 Plenum Press, New York
About this chapter
Cite this chapter
Stötter, G., Thune, S. (1970). Treatment of Acute Renal Failure and Chronic Renal Insufficiency with Additional Trasylol Therapy. In: Bertelli, A., Back, N. (eds) Shock: Biochemical, Pharmacological, and Clinical Aspects. Advances in Experimental Medicine and Biology, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3201-5_22
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3201-5_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3203-9
Online ISBN: 978-1-4684-3201-5
eBook Packages: Springer Book Archive